Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study.

Salvatore D'AngeloEnrico TirriAngela Maria GiardinoTiziana De RosaMarco Matucci-CerinicLorenzo DagnaLeonardo SantoFrancesco CicciaBruno FredianiMarcello GovoniFrancesca Bobbio PallaviciniRosa Daniela GrembialeAndrea Delle SedieRita MulèFrancesco Paolo CantatoreRosario FotiElisa GremesePaola ConigliaroFausto SalaffiOmbretta ViapianaAlberto CauliRoberto GiacomelliLuisa ArcareseGiuliana GugginoRomualdo RussoAmy PuenpatomDomenico CapocottaFrancesca NacciMaria Grazia AnelliValentina PicernoCorrado BinettiFlorenzo Iannonenull null

Published in: International journal of rheumatic diseases (2024)

Keyphrases

rheumatoid arthritis
ankylosing spondylitis
end stage renal disease
disease activity
ejection fraction
newly diagnosed
randomized controlled trial
chronic kidney disease
systematic review
peritoneal dialysis
interstitial lung disease
systemic sclerosis
adverse drug
drug induced